Menu

Search Results for "covid-19"

Mentre Segnalazioni di Reazione Avverse avvenute Dopo la somministrazione di vaccini contro il COVID-19 si avvicinano alla soglia di un milione di casi, il CDC e la FDA (Food and Drug Administration, ente federale statunitense per il controllo degli alimenti e dei medicinali) autorizzano i Booster della Pfizer e della Moderna per tutti gli adulti.

I dati del VAERS rilasciati oggi dal CDC comprendono un totale di 894.145 segnalazioni di reazioni avverse provenienti da tutte le fasce di età in seguito alle vaccinazioni anti-COVID, compresi 18.853 decessi e 139.126 gravi danni nel periodo tra il 14 dicembre 2020 e il 12 novembre 2021.

Ivermectin for COVID-19: real-time meta analysis of 65 studies

Ivermectin is an effective treatment for COVID-19. Treatment is more effective when used early. Meta analysis using the most serious outcome reported shows 66% [53‑76%] and 86% [75‑92%] improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis and restriction to peer-reviewed studies or Randomized Controlled Trials.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests

The COVID-19 pandemic caused increased mortality in nursing homes due to its quick spread and the age-related high lethality.

Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities

The clinical experience of this case series indicates DOXY-HCQ treatment in high-risk COVID-19 patients is associated with a reduction in clinical recovery, decreased transfer to hospital, and decreased mortality were observed after treatment with DOXY-HCQ.

COVID-19 mortality risk factors in older people in a long-term care center

Male gender, low Barthel index, and lymphocytopenia are independent risk factors for COVID-19 mortality in institutionalized older patients in long-term care nursing homes. Treatment with hydroxychloroquine and azithromycin was associated with lower mortality in these patients.

Effectiveness of a On-site Medicalization Program for Nursing Homes With COVID-19 Outbreaks

A coordinated on-site MP of nursing homes with COVID-19 outbreaks achieved a higher SOPC rate, and a reduction in referrals to hospital, thus ensuring rigorous but also humanistic and gentle care to residents.

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2 and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of hydroxychloroquine on respiratory viral loads.

Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial

This natural trial showed that the COVID-19 regimen containing both HCQ and azithromycin can be helpful to promote the recovery of most patients and reduced their signs and symptoms significantly.

Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review

Evidence is not sufficiently strong to either promote or refute the efficacy of IVM, DOXY, or their combination in COVID-19 management.

Ivermectin: an award-winning drug with expected antiviral activity against COVID-19

Ivermectin is an FDA-approved antiparasitic agent, being currently investigated in COVID-19 patients.

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

The authors declare that there are no known competing financial interests or personal relationships that could have appeared to influence the work described in this paper.

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.

Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial

We examined whether existing licensed pharmacotherapies could reduce the spread of coronavirus disease 2019 (COVID-19).

Tucker Carlson chiede: “Dov’è il dibattito sulle cure per la COVID-19?”

Il dottor Peter McCullough, autore dell’articolo più scaricato dell’American Journal of Medicine sui trattamenti COVID, ha stimato che l’85% delle morti per COVID avrebbero potuto essere evitate se i funzionari sanitari, i politici e i medici si fossero concentrati meno sui vaccini e più sulle terapie preventive precoci.

Increased risk for Covid-19 in patients with Vitamin D deficiency.

Vit D deficiency increased likelihood of being COVID-19 positive by 4.6 times.

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.

Hospitalized COVID-19 patients with diabetes had a 85.7% lower death rate when given Vit D.

Nutrients, Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.

Observational study showing improved immune system activity if supplementation was given to Vit D insufficient and deficient patients.

Nutrients, High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.

An 80% decrease in death among hospitalized (late treatment) patients in the UK given Vitamin D.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests.

Italian nursing home patients given Vitamin D before being exposed to COIVD 19 had a 70% decrease in death.

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).

Early treatment of COVID-19 with sequential multidrug treatment (SMDT) that has been shown to be safe and effective for non-hospitalized patients with symptoms of COVID 19.

Vitamin D Status is Associated With In-hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients

Patients with higher Vitamin D levels had significantly lower death rate.

Commentary: Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

The risk antibody‐dependent enhancement (ADE) during COVID-19 vaccine trials was sufficiently obscured in clinical trial protocols and consent forms that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Prospects for a safe COVID-19 vaccine

Although animal models of SARS-CoV-2 infection may elucidate mechanisms of immune protection, we need observations of enhanced disease in people receiving candidate COVID-19 vaccines to understand the risk of immune enhancement of disease. Neither principles of immunity nor preclinical studies provide a basis for prioritizing among the COVID-19 vaccine candidates with respect to safety at this time.

Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide

There is a positive association between COVID-19 deaths and Influenza Vaccination Rate (IVR) of people ≥65 years-old.

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

The activity of hydroxychloroquine on viruses is probably the same as that of chloroquine since the mechanism of action of these two molecules is identical so there is a strong rationality for the use of chloroquine to treat SARS-CoV-2-related pneumonia (named COVID-19).

Mentre gli australiani cercano risarcimento per le lesioni da vaccino secondo il nuovo piano, ecco uno sguardo alle leggi sulla responsabilità del vaccino COVID in tutto il mondo

Più di 10.000 australiani hanno finora richiesto un risarcimento per le lesioni da vaccino COVID nell’ambito del programma di risarcimento delle lesioni da vaccino del paese. Quali tipi di programmi di risarcimento esistono in altri paesi?

RFK Jr. a Milano: Sotto il Capitalismo Globale, esistono solo due classi — la classe d’élite e chiunque altro.

In un recente discorso tenutosi a Milano, Robert F. Kennedy, Jr. ha commentato che i miliardari sono miliardari — non importa se hanno fatto i soldi da monopoli statali in Cina o da monopoli illegali negli Stati Uniti.

RFK, Jr. Dice al periodico, The New American: Fauci ha una ‘storia oscura’ che deve essere esposta

In un episodio della trasmissione di video interviste online: “Conversations That Matter” (Conversazioni Importanti), Robert F. Kennedy, Jr, autore del libro: “The Real Anthony Fauci”, ha detto al conduttore Alex Newman che Fauci ha una “storia oscura” che deve essere esposta.

La variante Omicron: Molto rumore per nulla?

L’Organizzazione Mondiale della Sanità avverte che la variante Omicron può diffondersi più rapidamente delle altre varianti. Questo è probabilmente vero, ma in base alla scienza, questo non significa che la variante sia più letale della Delta o di altre – infatti, è probabilmente più mite.

I vaccini Pfizer e Moderna ‘aumentano in modo drammatico’ il rischio di infarto, avverte un illustre cardiologo

In un’analisi presentata durante una riunione dell’American Heart Association, il Dr. Steven Gundry, un pioniere nella chirurgia del trapianto di cuore infantile, ha detto che i vaccini anti COVID a mRNA mettono molti pazienti a un rischio più elevato di sviluppare una sindrome coronarica acuta, come un attacco di cuore.